Tapentadol is partially metabolized because of the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with drugs that greatly enhance or repress the activity/expression of a number of of such enzymes, and also with substrates of such enzymes (resulting from Opposition for the enzyme); some enzyme mediators/substrates requir… Read More